571190-30-2

URI: https://gptkb.org/entity/571190-30-2
GPTKB entity
Statements (30)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvedBy gptkb:European_Union
gptkb:United_States
gptkbp:ATCCode J05AE10
gptkbp:CASNumber gptkb:571190-30-2
gptkbp:component gptkb:Paxlovid
gptkbp:developedBy gptkb:Pfizer
gptkbp:drugClass antiviral drug
gptkbp:hasInChIKey RZGHCGFDDXNWQJ-GZNLMBLISA-N
gptkbp:hasMolecularFormula C23H32F3N5O4
gptkbp:hasSMILES CC(C)(C)[C@@H](NC(=O)C1CCCN1C(=O)C(C#N)NC(=O)C2CC3(C2)CN(C3)C)C(=O)N
gptkbp:hasUNII 4TDS8G671B
https://www.w3.org/2000/01/rdf-schema#label 571190-30-2
gptkbp:isCombinedWith gptkb:ritonavir
gptkbp:IUPACName (1R,2S,5S)-N-((1S)-1-cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
gptkbp:KEGGID D12372
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction SARS-CoV-2 main protease inhibitor
gptkbp:molecularWeight 499.5 g/mol
gptkbp:name gptkb:PF-07321332
gptkb:Nirmatrelvir
gptkbp:PubChem_CID gptkb:CHEMBL4297599
155903259
DB16357
107977417
gptkbp:routeOfAdministration oral
gptkbp:usedFor gptkb:COVID-19
gptkbp:bfsParent gptkb:Ibrance
gptkb:palbociclib
gptkbp:bfsLayer 7